Evaluation of the toxicity of the pertussis component of the Di-Te-Per vaccine
Gołobów, M.; Kardymowicz, B.; Kudelski, Z.; Rymkiewicz, D.; Sawicki, J.
Medycyna Doswiadczalna i Mikrobiologia 38(1): 9-14
1986
ISSN/ISBN: 0025-8601 PMID: 2423821 Document Number: 267601
Document emailed within 1 workday
Related Documents
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868
Ginnaga, A.; Morokuma, K.; Furukawa, S.; Shigaki, T.; Katsuki, N.; Aihara, K.; Oka, T.; Sakoh, M.; Tamura, C.; Imaizumi, A. 1991: Further evaluation of the pertussis component vaccine produced by apoceruloplasmin affinity chromatography Developments in Biological Standardization 73: 233-241
De Wildt, D.J.; de Jong, Y.; Nijkamp, F.P.; Kreeftenberg, J.G. 1985: Pharmacological evaluation of purified component and whole-cell pertussis vaccine in the cardiovascular system of rats Journal of Pharmacology and Experimental Therapeutics 232(2): 541-544
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Aleksandrova, L.Z.; Baeva, E.A.; Glinskaia, E.V.; Auzinia, A.V.; El'nitskaia, E.A. 1982: Antigenic similarity of the pertussis component of adsorbed DTP vaccine to human erythrocytes Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 82-88
Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Zawadka, M.; Rabczenko, D.; Lutyńska, A. 2014: Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines Medycyna Doswiadczalna i Mikrobiologia 66(3-4): 185-194
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Kumar, B.D.; Kumar, P.U.; Krishna, T.P.; Kalyanasundaram, S.; Suresh, P.; Jagadeesan, V.; Hariharan, S.; Naidu, A.N.; Krishnaswamy, K.; Rangarajan, P.N.; Srinivasan, V.A.; Reddy, G.S.; Sesikeran, B. 2013: Pre-clinical toxicity and immunobiological evaluation of DNA rabies vaccine and combination rabies vaccine in rhesus monkeys (Macaca mulatta) Indian Journal of Medical Research 137(6): 1072-1088
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41
Fradkin, V.A.; Lodinova, L.M.; Lavrenchik, E.I. 1994: An evaluation of the allergizing properties of merthiolate as a component of adsorbed DTP vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 38-42
Mortimer, E.A. 1990: Pertussis and pertussis vaccine: 1990 Advances in Pediatric Infectious Diseases 5: 1-33
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322